Silence Therapeutics (SLN) Current Leases (2019 - 2026)
Silence Therapeutics (SLN) posted Current Leases of $93000.0 for Q1 2026, up 4.49% sequentially from $89000.0 in Q4 2025, and up 55.0% YoY from $60000.0 in Q1 2025.
Silence Therapeutics (SLN) Current Leases (2019 - 2026) Analysis & Trends
Silence Therapeutics has reported Current Leases for 8 years, with the latest figure at $93000.0 in Q1 2026.
- Quarterly Current Leases rose 55.0% year-over-year to $93000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $93000.0 (up 55.0% YoY) and the FY2025 annual result came in at $89000.0, down 23.93% from the prior year.
- Current Leases rose to $93000.0 in Q1 2026 per SLN's latest filing, from $89000.0 in the prior quarter.
- Over five years, Current Leases peaked at $523126.0 in Q4 2022 and troughed at $60000.0 in Q1 2025.
- A 5-year average of $169898.9 and a median of $93000.0 in 2026 frame the typical range for Current Leases.
- The sharpest annual moves came in 2022 and 2023: Current Leases soared 183.26% in 2022, then plunged 57.53% in 2023.
- Over 5 years, Current Leases stood at $523126.0 in 2022, then slumped by 57.53% to $222166.2 in 2023, then sank by 47.34% to $117000.0 in 2024, then dropped by 23.93% to $89000.0 in 2025, then climbed by 4.49% to $93000.0 in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $93000.0, $89000.0, and $85000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Silence Therapeutics | 648.22 Mn | 576.12 Mn | - | 103,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 103,000.00 |
| Mar 31, 2026 | 93,000.00 |
| Dec 31, 2025 | 89,000.00 |
| Sep 30, 2025 | 85,000.00 |
| Mar 31, 2025 | 60,000.00 |
| Dec 31, 2024 | 117,000.00 |
| Dec 31, 2023 | 222,166.19 |
| Dec 31, 2022 | 523,126.03 |
| Dec 31, 2021 | 184,677.45 |
| Dec 31, 2020 | 450,273.79 |
| Dec 31, 2019 | 369,003.05 |